Trials / Completed
CompletedNCT04918212
Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection
Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection: A Prospective, Multi-center, Single Arm, Objective Performance Criteria Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 148 (actual)
- Sponsor
- Hangzhou Endonom Medtech Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, multi-center, objective performance criteria clinical trial to evaluate the safety and efficacy of Fabulous Stent Graft System manufactured by Hangzhou Endonom Medtech Co., Ltd. for Stanford B Aortic Dissection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fabulous Stent Graft System | All patients received endovascular surgery using fabulous stent graft system |
Timeline
- Start date
- 2017-11-25
- Primary completion
- 2020-10-13
- Completion
- 2020-10-13
- First posted
- 2021-06-08
- Last updated
- 2021-11-08
Locations
24 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04918212. Inclusion in this directory is not an endorsement.